Episode 304 showcases our hosts Dr Jake Sloane & David Segal.

In our 'What's trending in Aesthetics?' episodes we discuss popular topics doing the rounds on social media, issues being debated in injector forums or items showcased on the news. We'll cover controversies, big stories and themes that have got injectors and our industry talking.

In chapter 12 we discuss the decline of HA filler use around the world and the rise of biostimulators. We then predict a future potential serious problem as a result of this new trend.

We reflect on how these trends intersect with the continuing consolidation on the market and pressures on clinics, suppliers and the shifting role of pharma BDM's (reps).

We then explore the ramifications of the FDA's decision to compounded GLP 1 medications in the USA.

Finally we update our audience about our IA Competition draw (join us tonight on IG Live), new bonus content, and Dr Jake & David's upcoming travel plans.

00:00 Introduction

00:31 Exciting Announcements and Updates

01:28 Exploring Bonus Content and Collaborations

03:50 Trends in Aesthetic Treatments

05:36 Concerns with Overuse of Biostimulators

12:21 Regenerative Aesthetic Solutions

21:04 Counterfeit Devices in the Market

23:27 The Risks of Buying Aesthetic Products

23:55 Economic Pressures and Desperate Solutions

24:26 Counterfeit Products and Regulatory Support

27:25 The Role of Reps in the Changing Market

36:25 Compounded Drugs and FDA Regulations

43:10 Final Thoughts and Upcoming Content

ALL IA LINKS & CONTACT INFORMATION